Search Results - "Godeneche, G."

Cerebrovascular diseases and... skin abnormalities that disclose the diagnosis by Neau, J-P, Godeneche, G

“…In many cases, the diagnostic work-up after a stroke can be greatly enhanced by a thorough examination of the skin, since vasculitis or vasculopathies, even if…”
Get full text

Stroke and aspirin non-responder patients: Relation with hypertension and platelet response to adenosine diphosphate by Godeneche, G., Sorel, N., Ragot, S., Chomel, J. C., Neau, J. P., Macchi, L.

“…Despite its widespread use, there are many concerns about the efficacy of aspirin in the secondary prevention of cardiovascular events after stroke, leading to…”
Get full text

Vitamin D and multiple sclerosis. A prospective survey of patients of Poitou-Charentes area by Neau, J P, Artaud-Uriot, M S, Lhomme, V, Bounaud, J Y, Lebras, F, Boissonnot, L, Moinot, N, Ciron, J, Larrieu, D, Mathis, S, Godeneche, G, Ingrand, P

“…Recent reports demonstrate the implication of vitamin D in multiple sclerosis (MS). In a multicentric regional study (Poitou-Charentes area) during the first…”
Get full text

Muscular metastasis by Mathis, S, Fromont-Hankard, G, du Boisguéheneuc, F, Godenèche, G, Mahieu, F, Balaboi, I, Nocon, C, Marsac, E, Neau, J-P

“…Neoplasia is quite rare in myology. For unknown reasons, muscular metastasis are rarely described in cancer. Our work was a retrospective study with analysis…”
Get full text

Affections vasculaires cérébrales et… les anomalies cutanées qui font le diagnostic by Neau, J.-P., Godeneche, G.

“…L’enquête étiologique après un accident vasculaire cérébral (AVC) est facilitée par l’examen cutané car un certain nombre de vascularites ou de vasculopathies…”
Get full text

Capacities of atrial fibrillation detection after stroke: a French nationwide survey by Guidoux, C, Sibon, I, Alamowitch, S, Godeneche, G, Guillon, B, Timsit, S, Sablot, D, Cordonnier, C, Tardy, J, Granier, M, Extramiana, F, Cohen, A, Touze, E, Gaillard, N

Get full text

Multiple sclerosis: immunomodulators, education, and self-injection by Moinot, N, Anne, O, Devoize, J-L, Artaut-Uriot, M S, Aubert-Cetou, I, Boissonnot, L, Debras, C, Lebras, F, Loll, P-Y, Godeneche, G, Mesnage, V, Neau, J-P

“…One hundred and sixty four patients of the Poitou-Charentes area suffering from multiple sclerosis (MS) and treated with an immunomodulating agent for more…”
Get full text

P25—Late Diagnosis of Fabry Disease with Cardiovascular Manifestations by Godenèche, G, Germain, D, Degand, B, Vandermarcq, P, Neau, J.P.H

“…Case Description In October 2008, a 59-year-old man presented with a stroke in the vertebrobasilar territory. Since 1990, he had multiple transient neurologic…”
Get full text

Vitamine D et sclérose en plaques. Étude prospective d’une cohorte de patients de la région Poitou-Charentes by Neau, J.-P., Artaud-Uriot, M.-S., Lhomme, V., Bounaud, J.-Y., Lebras, F., Boissonnot, L., Moinot, N., Ciron, J., Larrieu, D., Mathis, S., Godeneche, G., Ingrand, P.

“…Des travaux récents montrent l’implication de la vitamine D dans la sclérose en plaques (SEP). Dans un travail pluricentrique régional (région…”
Get full text

Study of accessory deep peroneal nerve motor conduction in a population of healthy subjects by Mathis, S, Ciron, J, du Boisguéheneuc, F, Godenèche, G, Hobeika, L, Larrieu, D, Neau, J.-P

“…Summary Aim of the study The short extensor muscle of the toes ( extensor digitorum brevis ) is innervated by the deep peroneal nerve (DPN) but can also…”
Get full text

Sclérose en plaques : immunomodulateurs, éducation et auto-injection by Moinot, N., Anne, O., Devoize, J.-L., Artaut-Uriot, M.S., Aubert-Cetou, I., Boissonnot, L., Debras, C., Lebras, F., Loll, P.-Y., Godeneche, G., Mesnage, V., Neau, J.-P.

“…Un auto-questionnaire réalisé chez 164 patients de la région Poitou-Charentes atteints de sclérose en plaques traitée depuis plus de trois mois par un…”
Get full text

Ergotisme chronique : atteinte médullaire et mononeuropathie by Sallansonnet-Froment, M., Guegan-Massardier, E., Blohorn-Sense, A., Triquenot-Bagan, A., Godeneche, G., Onnient, Y., Mihout, B.

“…Les manifestations neurologiques dues à l’ergotisme chronique sont rares. Nous rapportons le cas d’une patiente de 40 ans ayant présenté des signes cliniques…”
Get full text

Une ≪ lupique ≫ qui perd la mémoire by Godeneche, G., Lévesque, H., Delangre, T., François, A., Thiberville, L., Courtois, H.

Get full text

Stroke and aspirin non-responder patients: Relation with hypertension and platelet response to adenosine diphosphate by Godeneche, G., Sorel, N., Ragot, S., Chomel, J. C., Neau, J. P., Macchi, L.

Get full text

Mammary Hypertrophy and Depression Induced by Oxetorone: Two Case Reports by Lafay-Chebassier, C, Godeneche, G, Descriaud, A, Neau, J P, Perault-Pochat, M C

Get full text

Les métastases des muscles striés by Mathis, S., Fromont-Hankard, G., du Boisguéheneuc, F., Godenèche, G., Mahieu, F., Balaboi, I., Nocon, C., Marsac, E., Neau, J.-P.

“…L’atteinte néoplasique du muscle est une entité assez peu répandue en myologie et les métastases musculaires, pour des raisons mal déterminées, sont assez peu…”
Get full text

JAK2 V617F mutation associated with cerebral venous thrombosis: a report of five cases by Godeneche, G, Gaillard, N, Roy, L, Mania, A, Tondeur, S, Chomel, J C, Lavabre, T, Arquizan, C, Neau, J P

Get more information

Un accident ischémique protubérantiel révélé par une paupière douloureuse by Mathis, S., Godenèche, G., Giré, P., Du Boisguéheneuc, F., Neau, J. -P.

“…Résumé Introduction La douleur oculaire représente une manifestation rare des accidents vasculaires cérébraux (AVC). Observation Nous rapportons le cas d’un…”
Get full text

Chronic ergotism: spinal lesion and neuropathy by Sallansonnet-Froment, M, Guegan-Massardier, E, Blohorn-Sense, A, Triquenot-Bagan, A, Godeneche, G, Onnient, Y, Mihout, B

“…Neuropathologic manifestations due to chronic ergotism are rare. We report the case of a 40-year-old patient who presented clinical signs and symptoms of a…”
Get full text

Immunomodulateurs et sclérose en plaques : que deviennent les aiguilles ? by Moinot, N., Anne, O., Neau, J.-P., Godeneche, G., Mesnage, V., Mesnage, V.

“…Les immunomodulateurs (ID) utilisés dans la sclérose en plaques sont injectables, générant des déchets, dont le patient est légalement responsable. Des…”
Get full text